PDE4C Assay Kit

Catalog #
60384
$800 *
Size: 384 reactions
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The PDE4C1 Assay Kit is designed for identification of PDE4C1 inhibitors using fluorescence polarization. The assay is based on the binding of a fluorescent nucleotide monophosphate generated by PDE4C1 to the binding agent. The key to the PDE4C1 Assay Kit is the specific binding agent. Using this kit, only two simple steps on a microtiter plate are required for PDE4C1 reactions. First, the fluorescently labeled cAMP is incubated with a sample containing PDE4C1 for 1 hour. Second, a binding agent is added to the reaction mix to produce a change in fluorescent polarization. The FP signal is measured using a fluorescent microplate reader capable of measuring fluorescence polarization.

Synonyms
PDE4-C, PDE
Product Info
Storage and Usage
Citations
Assay Kit Format
Fluorescence Polarization
Supplied As
The PDE4C1 inhibitor screening assay kit comes in a convenient 384-well format, including purified PDE4C1 enzyme, fluorescently labeled PDE4C1 substrate (cAMP), binding agent, and PDE assay buffer for 400 enzyme reactions.
Format

Catalog #

Component

Amount

Storage

60044

PDE4C1 recombinant enzyme

1 µg

-80°C

(Avoid freeze/ thaw cycles!)

60200

FAM-Cyclic-3′, 5′-AMP: 20 µM

50 µl

-80°C

60393

PDE assay buffer

25 ml

-20°C

60390

Binding Agent

250 µl

+4°C

60391

Binding Agent Diluent (cAMP)

25 ml

+4°C

 

Black, low binding, 384 microtiter plate

1

Room temp.

UniProt #
Q08493
Background
Phosphodiesterases (PDEs) play an important role in dynamic regulation of cAMP and cGMP signaling. PDE4C selectively hydrolyzes cAMP and is a candidate biomarker for human glioma. Research suggests that PDE4C functions as a tumor suppressor, and downregulation of PDE4C in glioma patients correlates with poor prognosis.
References
Chandrasekaran, A., et al., Cell Signal. 2008; 20(1):139-53.